RAISED CEREBROSPINAL-FLUID COPPER CONCENTRATION IN PARKINSON'S DISEASE
- 1 August 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 330 (8553), 238-241
- https://doi.org/10.1016/s0140-6736(87)90827-0
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Effect of Iron Chelators on Dopamine D2 ReceptorsJournal of Neurochemistry, 1985
- Glutathione peroxidase activity in Parkinson's disease brainNeuroscience Letters, 1985
- Age pigments and free radicals: fluorescent lipid complexes formed by iron- and copper-containing proteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Diagnosis and epidemiology of Parkinson's diseaseActa Neurologica Scandinavica, 1983
- Manganese neurotoxicity: a model for free radical mediated neurodegeneration?Canadian Journal of Physiology and Pharmacology, 1982
- Selective inhibition of the polymerase activity of DNA polymerase I. Further evidence for separate active sites for polymerase and 3' to 5' exonuclease activitiesBiochemistry, 1979
- FREE-RADICAL OXIDATION AND ANTIOXIDANTSThe Lancet, 1978
- L-dopa and cerebrospinal fluid homovanillic acid in parkinsonismLife Sciences, 1969
- ParkinsonismNeurology, 1967
- THE DISTRIBUTION OF COPPER IN HUMAN BRAINBrain, 1960